In breast cancer cells, impairment of Orai1 function or expression using dominant negative mutants or specific RNAi attenuates proliferation and migration, arrests cell cycle progression and reduces the viability and the resistance to chemotherapeutic agents as well as self-renewal of breast cancer stem cells [27,32,33,34,35]. This evidence concerns the gene ORAI1 and breast carcinoma.